
1 

(1) This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1995 and shall come into force on 1st January 1996.
(2) In this Order, “the principal Order” means the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984.
(3) In this Order, a reference to inserting an entry in a column in a Table of Schedule 1 to the principal Order shall be construed, in the case of an entry to be inserted in column 1, as a reference to inserting that entry at the appropriate point in the alphabetical order of the entries in column 1 of that Table and, in the case of an entry to be inserted (as the case may be) in column 2, 3 or 4 of that Table, as a reference to inserting that entry so as to appear against the column 1 entry against which it is listed in Schedule 1 or, as the case may be, Schedule 2 to this Order.
2 

(1) Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of that Order) is amended in accordance with the following provisions of this article.
(2) In Table A (internal or external use)—
(a) there are inserted in column 1 and, as the case may be, columns 2, 3 and 4, the entries set out in columns 1, 2, 3 and 4 respectively of Schedule 1 to this Order;
(b) in relation to the substance “Benzoin Tincture, Compound BP”—
(i) there is inserted in column 2 the entry“
(2) 0.8 per cent.”, and
(ii) there are substituted, for the entries in column 3, the entries“
(1) Internal: vapour inhalations
(2) Internal: pastilles
(3) External”;
(c) in relation to the substance “Folic Acid”, there is substituted for the entry in column 4 the entry “500 mcg (MDD)”.
(3) In Table B (external use only), there are inserted in column 1 and, as the case may be, columns 2 and 3, the entries set out in columns 1, 2 and 3 respectively of Schedule 2 to this Order.
Signed by authority of the Secretary of State for Health
Gerald Malone
Minister of State
Department of Health
4th December 1995William Hague
Secretary of State for Wales
11th December 1995James Douglas Hamilton
Minister of State The Scottish Office
11th December 1995Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on
F. A. Elliott
Permanent Secretary
7th December 1995.
SCHEDULE 1
Article 2(2)(a)


Column 1 Column 2 Column 3 Column 4
Substance Maximum strength Use, pharmaceutical form or route of administration Maximum dose and maximum daily dose
Choline Bitartrate
Equisetum
Ibuprofen 
(1) 200 mg 
(1) Internal: tablets, capsules, powder or granules, in each case for use in adults and in children over the age of 12 years only and for treatment of the following only–
 rheumatic or muscular pain
 backache
 neuralgia
 migraine
 headache
 dental pain
 dysmenorrhoea
 feverishness
 symptoms of colds and influenza 
(1) 400 mg (MD) 1200 mg (MDD)
 
(2) 5.0 per cent. 
(2) External: for use in adults and in children over the age of 12 years only and for treatment of the following only–
 rheumatic pain
 muscular aches
 pains or swellings such as strains, sprains and sports injuries 
(2) 125 mg (MD) 500 mg (MDD)
Magnesium Alginate
SCHEDULE 2
Article 2(3)


Column 1 Column 2 Column 3
Substance Maximum strength Use, pharmaceutical form or route of administration
Capsicum Oleoresin
Capsicum Oleoresin (Water soluble)
Clotrimazole 1.0 per cent. For treatment of tinea pedis (athlete’s foot) only